Management of Hereditary Breast Cancer: American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Guideline.


Journal

Journal of clinical oncology : official journal of the American Society of Clinical Oncology
ISSN: 1527-7755
Titre abrégé: J Clin Oncol
Pays: United States
ID NLM: 8309333

Informations de publication

Date de publication:
20 06 2020
Historique:
pubmed: 4 4 2020
medline: 3 2 2021
entrez: 4 4 2020
Statut: ppublish

Résumé

To develop recommendations for management of patients with breast cancer (BC) with germline mutations in BC susceptibility genes. The American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology convened an Expert Panel to develop recommendations based on a systematic review of the literature and a formal consensus process. Fifty-eight articles met eligibility criteria and formed the evidentiary basis for the local therapy recommendations; six randomized controlled trials of systemic therapy met eligibility criteria. Patients with newly diagnosed BC and

Identifiants

pubmed: 32243226
doi: 10.1200/JCO.20.00299
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2080-2106

Auteurs

Nadine M Tung (NM)

Beth Israel Deaconess Medical Center, Boston, MA.

Judy C Boughey (JC)

Mayo Clinic, Rochester, MN.

Lori J Pierce (LJ)

Rogel Cancer Center, University of Michigan, Ann Arbor, MI.

Mark E Robson (ME)

Memorial Sloan Kettering Cancer Center, New York, NY.

Isabelle Bedrosian (I)

The University of Texas MD Anderson Cancer Center, Houston, TX.

Jill R Dietz (JR)

Case Western Reserve University School of Medicine and University Hospitals, Cleveland, OH.

Anthony Dragun (A)

MD Anderson-Cooper University Hospital, Camden, NJ.

Judith Balmana Gelpi (JB)

Vall d'Hebron University Hospital, Barcelona, Spain.

Erin W Hofstatter (EW)

Yale Cancer Center, New Haven, CT.

Claudine J Isaacs (CJ)

Georgetown University, Washington, DC.

Ismail Jatoi (I)

University of Texas Health Science Center at San Antonio, San Antonio, TX.

Elaine Kennedy (E)

FORCE, Washington, DC.

Jennifer K Litton (JK)

The University of Texas MD Anderson Cancer Center, Houston, TX.

Nina A Mayr (NA)

University of Washington, Seattle, WA.

Rubina D Qamar (RD)

Advocate Aurora Health, Milwaukee, WI.

Mark G Trombetta (MG)

Allegheny Health Network, Pittsburgh, PA.

Brittany E Harvey (BE)

American Society of Clinical Oncology, Alexandria, VA.

Mark R Somerfield (MR)

American Society of Clinical Oncology, Alexandria, VA.

Dana Zakalik (D)

Beaumont Health, Royal Oak, MI.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH